Home/Keranova/Denise Hoblingre

DH

Denise Hoblingre

CEO

Therapeutic Areas

Keranova Pipeline

Drug	Indication	Phase
FemtoMatrix® Surgical Suite	Cataract Surgery (Anterior Segment Surgery)	Pre-clinical

Leadership Team at Keranova

Aurélien Bernard

Chief Scientific Officer

Emmanuel Baubeau

Chief Technical Officer

Chairman of the Board

View full Keranova profile